The Indiana Clinical and Translational Sciences Institute will host its 2026 Annual Meeting, “Genetic Medicine from Sequence to Solution,” on Friday, September 18, at Hine Hall on the IU Indianapolis campus.

The program will feature researchers from Indiana’s leading research institutions presenting work across gene therapy, pharmacogenomics, cancer biology, immunotherapy, neuroregeneration, metabolism and precision medicine.

Kevin Campbell, PhD, of the University of Iowa and recipient of the 2026 August M. Watanabe Prize in Translational Research, will deliver the keynote address on molecular mechanisms and therapeutic strategies for muscular dystrophy.

The meeting will also include a research showcase, a panel discussion about translating advances in genetic medicine into patient care and a plenary presentation by Andrew Harmon, PhD, of the U.S. Food and Drug Administration. A networking reception will follow the program.

This is an in-person event. Registration is required.

Event details

Date: Friday, September 18, 2026
Time: 8:30 a.m. to 4 p.m.
Location: Hine Hall Auditorium, IU Indianapolis
Address: 875 W. North Street, Indianapolis, IN 46202